OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. A variety of strategies are employed maximize antibody titer, such as process parameter optimization, cell line development, and implementation of perfusion technologies. Fine-tuning culture